Genprex Inc (GNPX)
2.51
+0.09
(+3.72%)
USD |
NASDAQ |
May 17, 16:00
2.51
0.00 (0.00%)
After-Hours: 20:00
Genprex Cash from Financing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 6.513M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 4.081M |
| December 31, 2022 | 0.0047M |
| September 30, 2022 | 0.0018M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.2435M |
| June 30, 2021 | 0.11M |
| March 31, 2021 | 25.32M |
| December 31, 2020 | 12.50M |
| September 30, 2020 | 0.7936M |
| June 30, 2020 | 2.569M |
| March 31, 2020 | 25.73M |
| Date | Value |
|---|---|
| December 31, 2019 | 1.267M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.4168M |
| September 30, 2018 | -0.2148M |
| June 30, 2018 | 15.11M |
| March 31, 2018 | 0.0774M |
| December 31, 2017 | -0.00 |
| September 30, 2017 | 0.565M |
| June 30, 2017 | 0.229M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 1.50M |
| September 30, 2016 | 1.161M |
| June 30, 2016 | 0.045M |
| March 31, 2016 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
25.73M
Maximum
Mar 2020
4.165M
Average
0.11M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
| Lifecore Biomedical Inc | 40.93M |
| Jaguar Health Inc | 12.27M |
| Aquestive Therapeutics Inc | 81.74M |
| TFF Pharmaceuticals Inc | 0.0006M |
| Calidi Biotherapeutics Inc | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.964M |
| Cash from Investing (Quarterly) | -0.0098M |
| Free Cash Flow | -24.81M |
| Free Cash Flow Per Share (Quarterly) | -3.344 |
| Free Cash Flow Yield | -711.6% |